Jordan’s pharmaceutical exports surges by 29.7% in first 5 months of 2023

doctor writing a medical prescription drug drugs
(File photo: Jordan News)
AMMAN — The pharmaceutical industries and medical supplies sector in Jordan have witnessed significant growth in exports, with an increase of 29.7 percent during the first five months of this year compared to the corresponding period last year.اضافة اعلان

Export figures provided by Fadi Al-Atrash, the sector's representative at the Jordan Chamber of Industry, reveal that exports reached approximately JD266 million in the initial five months of this year, marking a noteworthy rise from JD205 million in the same period last year.

Exports enter 85 global marketsAccording to the Jordan News Agency, Petra, Atrash declared that the sector's exports have successfully reached 85 global markets.

The growth in the pharmaceutical industry has been registered across the three chambers of industry in the Kingdom, with Zarqa witnessing a 63.7 percent increase, Amman 28.5 percent, and the Irbid Chamber of Industry observing a 9.8 percent growth.

Regularized supply chains and recovery drive growthAtrash attributed this growth to the regularization and recovery of supply chains, which has ensured an uninterrupted supply of raw materials, packaging, and production inputs.

The production chain has also played a vital role in boosting production and sales, Atrash said.

Atrash also acknowledged the resilience of companies that have bounced back from the adverse impact of the COVID-19 pandemic, targeting growth and expansion into new and non-traditional markets.

European market access and export resumption to Algeria
The sector representative highlighted that some firms have secured European Good Manufacturing Practice Certificates, enabling them to export to the lucrative European market.

Additionally, he noted the resumption of export activities to Algeria, which stands as one of the largest pharmaceutical markets in the region.

Atrash applauded the unwavering support of the Jordan Food and Drug Administration in expediting the registration of local products, which has subsequently led to the expansion of exports.

He emphasized the uniqueness and diversity of modern and innovative pharmaceutical forms, as well as the advancement of production lines, reflecting the significant development of the Jordanian medicine and medical supplies industry.

Regional hub for pharmaceutical manufacturing
Furthermore, Atrash stressed the importance of a robust public-private partnership in empowering the sector to become a regional hub for pharmaceutical manufacturing.

Such cooperation also facilitates investment in research and development, leading to the production of new therapeutic groups that positively influence the growth of Jordanian exports.

Jordan's pharmaceutical sector at a glance
The pharmaceutical and medical supplies sector in Jordan comprises 151 facilities with a registered capital of about JD341 million. Additionally, there are 15 Jordanian factories operating outside the Kingdom, specifically in Saudi Arabia, Algeria, Egypt, Morocco, and Sudan.

Reflecting on the vision of economic modernization, Atrash underscored its pivotal role in supporting the sector as a vital and steadily growing industry. The vision aims to enhance exports to reach 2.1 billion dinars, create employment for 16,000 individuals, and increase the contribution to the GDP to JD1.7 billion by 2033.

Atrash, who also serves as CEO and Board Member of the Amman Pharmaceutical Industries, mentions the vision's ambition to attract investments worth JD1.1 billion over the next decade.

This influx of investment will aid in transforming the sector into a regional center for pharmaceutical products through technological adoption, development of new drugs, market expansion, and achieving pharmaceutical security for Jordan and the surrounding region.

Read more National news
Jordan News